Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
The Journal of Antimicrobial Chemotherapy
|
December 4, 2014
Epidemiology and risk factors for infections due to AmpC β-lactamase-producing Escherichia coli
Vanesa Pascual, Gabriel Ortiz, Maria Simó, et al.
Antimicrobial Agents and Chemotherapy
|
February 12, 2020
Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an <i>In Vitro</i> Pharmacodynamic Model
María Montero, Sandra Domene Ochoa, Carla López-Causapé, et al.
The Journal of Hospital Infection
|
April 30, 2025
Successful implementation of a bundle to prevent increased excessive-spectrum antimicrobial use under new EUCAST susceptibility definitions: a quasi-experimental study in a tertiary hospital
Pol Duch Llorach, Antonella Francesca Simonetti, Abril Figueras Roig, et al.
International Journal of Antimicrobial Agents
|
November 27, 2015
Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates
Noemí Alonso, Elisenda Miró, Vanesa Pascual, et al.
Journal of Global Antimicrobial Resistance
|
June 3, 2019
Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones
María M Montero, Sandra Domene Ochoa, Carla López-Causapé, et al.
International Journal of Antimicrobial Agents
|
December 28, 2025
Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: a retrospective multicentre study
Miguel Ángel Consuegra Pérez, Sara Grillo, Alexander Rombauts, et al.
Journal of Clinical Microbiology
|
May 3, 2013
Epidemiological and clinical complexity of amoxicillin-clavulanate-resistant Escherichia coli
Jesús Rodríguez-Baño, Jesús Oteo, Adriana Ortega, et al.
Antimicrobial Agents and Chemotherapy
|
April 12, 2012
Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli
Adriana Ortega, Jesús Oteo, Maitane Aranzamendi-Zaldumbide, et al.
The Journal of Infection
|
November 8, 2015
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
Zaira R Palacios-Baena, Jesús Oteo, Carmen Conejo, et al.
The Journal of Antimicrobial Chemotherapy
|
August 3, 2023
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)
Federico Becerra-Aparicio, Silvia Gómez-Zorrilla, Marta Hernández-García, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
The Journal of Antimicrobial Chemotherapy
|
December 4, 2014
Epidemiology and risk factors for infections due to AmpC β-lactamase-producing Escherichia coli
Vanesa Pascual, Gabriel Ortiz, Maria Simó, et al.
Antimicrobial Agents and Chemotherapy
|
February 12, 2020
Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an <i>In Vitro</i> Pharmacodynamic Model
María Montero, Sandra Domene Ochoa, Carla López-Causapé, et al.
The Journal of Hospital Infection
|
April 30, 2025
Successful implementation of a bundle to prevent increased excessive-spectrum antimicrobial use under new EUCAST susceptibility definitions: a quasi-experimental study in a tertiary hospital
Pol Duch Llorach, Antonella Francesca Simonetti, Abril Figueras Roig, et al.
International Journal of Antimicrobial Agents
|
November 27, 2015
Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates
Noemí Alonso, Elisenda Miró, Vanesa Pascual, et al.
Journal of Global Antimicrobial Resistance
|
June 3, 2019
Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones
María M Montero, Sandra Domene Ochoa, Carla López-Causapé, et al.
International Journal of Antimicrobial Agents
|
December 28, 2025
Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: a retrospective multicentre study
Miguel Ángel Consuegra Pérez, Sara Grillo, Alexander Rombauts, et al.
Journal of Clinical Microbiology
|
May 3, 2013
Epidemiological and clinical complexity of amoxicillin-clavulanate-resistant Escherichia coli
Jesús Rodríguez-Baño, Jesús Oteo, Adriana Ortega, et al.
Antimicrobial Agents and Chemotherapy
|
April 12, 2012
Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli
Adriana Ortega, Jesús Oteo, Maitane Aranzamendi-Zaldumbide, et al.
The Journal of Infection
|
November 8, 2015
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
Zaira R Palacios-Baena, Jesús Oteo, Carmen Conejo, et al.
The Journal of Antimicrobial Chemotherapy
|
August 3, 2023
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)
Federico Becerra-Aparicio, Silvia Gómez-Zorrilla, Marta Hernández-García, et al.
Page
of 6